Evidence check: Cardio Risk Check in the context of fertility

The question of a 'Cardio Risk Check' in the context of fertility is nuanced. There is established evidence that cardiovascular risk factors—such as hypertension, obesity, elevated inflammation markers (e.g., hsCRP), and insulin resistance—can negatively impact fertility in both women and men. For example, endothelial dysfunction may impair blood flow to reproductive organs, and chronic inflammation can affect oocyte quality and sperm function. However, a generic 'Cardio Risk Check' product (e.g., based on DNA or blood markers) is not specifically validated for fertility assessment. Most such tests rely on general risk markers (e.g., cholesterol, CRP, single SNPs) whose predictive value for fertility is weak and unsupported by clinical trials. The evidence level is 'mixed' to 'marketing': there is a scientific rationale linking cardiovascular health to fertility, but the specific claims of these tests are often overstated. A negative result does not rule out fertility issues, and a positive result does not replace a medical workup. Anyone considering fertility treatment should pursue comprehensive reproductive diagnostics rather than a generic cardio check. The provided context contains no direct information on Cardio Risk Check and fertility.